Abstract
Background
The Flemish Collaborative Glomerulonephritis Group (FCGG) registry is a population-based kidney biopsy registry that has been including all native kidney biopsies performed in children in Flanders (Belgium), since 2017.
Methods
From 2017 to 2020, 148 pediatric (< 18 years) native kidney biopsies were included. Each biopsy received a histopathological and final nephrological diagnosis, and concordance between both was assessed. Disease chronicity, summarized by the Mayo Clinic Chronicity Score, was determined on 122 biopsies with > 5 glomeruli.
Results
Kidney biopsy rate was high (29.0 biopsies per million children per year), median age was 10.0 years (IQR 5.8–14.7), and boys predominated (56.1% males). A total of 140 biopsies (94.6%) showed a representative pathology result. Glomerular disease was most prevalent, with IgA nephropathy/IgA vasculitis (43 biopsies, 29.1%) and minimal change disease (MCD) (29 biopsies, 19.6%) being the overall most frequent diagnoses. In general, diagnostic concordance was high (80.7%). In Alport syndrome and focal segmental glomerulosclerosis (FSGS), concordance was lower, as the nephrological diagnosis was often determined by results of genetic analysis. Nephrotic syndrome was the most frequent indication for kidney biopsy (31.8%) and was mainly caused by MCD and FSGS. The degree of disease chronicity on kidney biopsies was generally low, although 27.3% of biopsies with a diagnosis of FSGS showed moderate-to-severe chronic damage.
Conclusions
The presented epidemiological findings validate data from previous European registry studies and may inspire kidney biopsy registries worldwide to implement novel features such as clinicopathological concordance and chronicity grading.
Graphical abstract
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding authors on reasonable request.
References
Najafian B, Lusco MA, Alpers CE, Fogo AB (2022) Approach to kidney biopsy: core curriculum 2022. Am J Kidney Dis 80:119–131. https://doi.org/10.1053/j.ajkd.2021.08.024
Siwy J, Zürbig P, Argiles A, Beige J et al (2017) Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis. Nephrol Dial Transplant 32:2079–2089. https://doi.org/10.1093/ndt/gfw337
Lodeweyckx N, Wouters K, Ledeganck KJ, Trouet D (2021) Biopsy or biomarker? Children with minimal change disease have a distinct profile of urinary epidermal growth factor. Front Pediatr 9:727954. https://doi.org/10.3389/fped.2021.727954
Fiorentino M, Bolignano D, Tesar V, Pisano A et al (2016) Renal biopsy in 2015 - from epidemiology to evidence-based indications. Am J Nephrol 43:1–19. https://doi.org/10.1159/000444026
Sethi S, D’Agati VD, Nast CC, Fogo AB et al (2017) A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Kidney Int 91:787–789. https://doi.org/10.1016/j.kint.2017.01.002
Srivastava A, Palsson R, Kaze AD, Chen ME et al (2018) The prognostic value of histopathologic lesions in native kidney biopsy specimens: results from the Boston Kidney Biopsy Cohort Study. J Am Soc Nephrol 29:2213–2224. https://doi.org/10.1681/ASN.2017121260
Coppo R, Gianoglio B, Porcellini MG, Maringhini S (1998) Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Nephrol Dial Transplant 13:293–297. https://doi.org/10.1093/oxfordjournals.ndt.a027821
Rivera F, López-Gómez JM, Pérez-García R (2002) Frequency of renal pathology in Spain 1994–1999. Nephrol Dial Transplant 17:1594–1602. https://doi.org/10.1093/ndt/17.9.1594
López-Gómez JM, Rivera F (2020) Spanish Registry of glomerulonephritis 2020 revisited: past, current data and new challenges. Nefrologia 40:371–383. https://doi.org/10.1016/j.nefroe.2020.08.004
Maixnerova D, Jancova E, Skibova J, Rysava R et al (2015) Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994–2011. J Nephrol 28:39–49. https://doi.org/10.1007/s40620-014-0090-z
Brazdziute E, Miglinas M, Gruodyte E, Priluckiene J et al (2015) Nationwide renal biopsy data in Lithuania 1994–2012. Int Urol Nephrol 47:655–662. https://doi.org/10.1007/s11255-015-0927-y
Fidan K, Isik Gonul I, Büyükkaragöz B, Isiyel E et al (2016) Changing trends in pediatric renal biopsies: analysis of pediatric renal biopsies in national nephrology registry data. Ren Fail 38:1228–1233. https://doi.org/10.1080/0886022X.2016.1209070
Perkowska-Ptasinska A, Bartczak A, Wagrowska-Danilewicz M, Halon A et al (2017) Clinicopathologic correlations of renal pathology in the adult population of Poland. Nephrol Dial Transplant 32:ii09-ii18. https://doi.org/10.1093/ndt/gfw365
Molnár A, Thomas MJ, Fintha A, Kardos M et al (2021) Kidney biopsy-based epidemiologic analysis shows growing biopsy rate among the elderly. Sci Rep 11:24479. https://doi.org/10.1038/s41598-021-04274-9
Dendooven A, Peetermans H, Helbert M, Nguyen TQ et al (2021) Coding practice in national and regional kidney biopsy registries. BMC Nephrol 22:193. https://doi.org/10.1186/s12882-021-02365-3
Laurens W, Deleersnijder D, Dendooven A, Lerut E et al (2022) Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registry. Clin Kidney J 15:1361–1372. https://doi.org/10.1093/ckj/sfac033
Venkat-Raman G, Tomson CRV, Gao Y, Cornet R et al (2012) New primary renal diagnosis codes for the ERA-EDTA. Nephrol Dial Transplant 27:4414–4419. https://doi.org/10.1093/ndt/gfs461
Tøndel C, Vikse BE, Bostad L, Svarstad E (2012) Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988–2010. Clin J Am Soc Nephrol 7:1591–1597. https://doi.org/10.2215/CJN.02150212
Hussain F, Mallik M, Marks SD, Watson AR (2010) Renal biopsies in children: current practice and audit of outcomes. Nephrol Dial Transplant 25:485–489. https://doi.org/10.1093/ndt/gfp434
McGrogan A, Franssen CFM, De Vries CS (2011) The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 26:414–430. https://doi.org/10.1093/ndt/gfq665
Coppo R (2019) Pediatric IgA nephropathy in Europe. Kidney Dis 5:182–188. https://doi.org/10.1159/000495751
Rivera F, López-Gómez JM, Pérez-García R (2004) Clinicopathologic correlations of renal pathology in Spain. Kidney Int 66:898–904. https://doi.org/10.1111/j.1523-1755.2004.00833.x
Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392:61–74. https://doi.org/10.1016/S0140-6736(18)30536-1
Kopp JB, Anders H-J, Susztak K, Podestà MA et al (2020) Podocytopathies. Nat Rev Dis Prim 6:68. https://doi.org/10.1038/s41572-020-0196-7
Kashtan CE, Ding J, Garosi G, Heidet L et al (2018) Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int 93:1045–1051. https://doi.org/10.1016/j.kint.2017.12.018
Kashtan CE, Gross O (2021) Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults–an update for 2020. Pediatr Nephrol 36:711–719. https://doi.org/10.1007/s00467-020-04819-6
Savige J (2018) Should we diagnose autosomal dominant Alport syndrome when there is a pathogenic heterozygous COL4A3 or COL4A4 variant? Kidney Int Rep 3:1239–1241. https://doi.org/10.1016/j.ekir.2018.08.002
Warejko JK, Tan W, Daga A, Schapiro D et al (2018) Whole exome sequencing of patients with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 13:53–62. https://doi.org/10.2215/CJN.04120417
Landini S, Mazzinghi B, Becherucci F, Allinovi M et al (2020) Reverse phenotyping after whole-Exome sequencing in steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 15:89–100. https://doi.org/10.2215/CJN.06060519
Zhang X, Xu J, Xiao H, Yao Y et al (2020) Value of electron microscopy in the pathological diagnosis of native kidney biopsies in children. Pediatr Nephrol 35:2285–2295. https://doi.org/10.1007/s00467-020-04681-6
Royal V, Zee J, Liu Q, Avila-Casado C et al (2020) Ultrastructural characterization of proteinuric patients predicts clinical outcomes. J Am Soc Nephrol 31:841–854. https://doi.org/10.1681/ASN.2019080825
Casal Moura M, Fervenza FC, Specks U, Sethi S (2021) Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfab250
Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R et al (2018) C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy. Kidney Int 93:977–985. https://doi.org/10.1016/j.kint.2017.10.022
Caravaca-Fontán F, Trujillo H, Alonso M, Díaz-Encarnación M et al (2021) Validation of a histologic scoring index for C3 glomerulopathy. Am J Kidney Dis 77:684-695.e1. https://doi.org/10.1053/j.ajkd.2020.11.011
Yin P, Wang J, Liang W, Zhan L et al (2020) Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study. Ren Fail 42:675–683. https://doi.org/10.1080/0886022X.2020.1792315
Chávez-Mendoza CA, Niño-Cruz JA, Correa-Rotter R, Uribe-Uribe NO et al (2019) Calcineurin inhibitors with reduced-dose steroids as first-line therapy for focal segmental glomerulosclerosis. Kidney Int Rep 4:40–47. https://doi.org/10.1016/j.ekir.2018.08.010
Stefan G, Busuioc R, Stancu S, Hoinoiu M et al (2021) Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome. Clin Exp Nephrol 25:240–250. https://doi.org/10.1007/s10157-020-01985-7
Acknowledgements
The authors wish to thank all collaborating nephrologists in Flanders and Brussels and responsible persons at the data entry centers (Elsie De Man, Sabine Verhofstede, Ben Sprangers) for their participation in the FCGG registry. The FCGG registry was initiated in collaboration with NBVN, a not-for-profit organization that represents nephrologists in Flanders.
Members of the FCGG collaborative group are mentioned in the Appendix. These members are collaborators, unless also mentioned in the author list above, in which case they are authors.
Funding
Dries Deleersnijder is supported by a PhD Fellowship grant fundamental research from the Research Foundation Flanders (F.W.O., grant number 11L5622N). Ben Sprangers is a senior clinical investigator of The Research Foundation Flanders (F.W.O., grant number 1842919 N). The FCGG registry is funded by the Nederlandstalige Belgische Vereniging voor Nefrologie (NBVN).
Author information
Authors and Affiliations
Consortia
Contributions
DD, NK, DT, KVH, SK, JVW, RM, LC, GM, AD, JDM, WL, and BS were responsible for the conception, design, and data acquisition of the study. DD, NK, LC, AD, JDM, WL, and BS were responsible for analysis and interpretation of the data.
DD, NK, DT, KVH, SK, JVW, RM, LC, GM, AD, JDM, WL, and BS drafted the work and revised it critically for important intellectual content.
DD, NK, DT, KVH, SK, JVW, RM, LC, GM, AD, JDM, WL, and BS approved the submitted version of the manuscript.
DD, NK, DT, KVH, SK, JVW, RM, LC, GM, AD, JDM, WL, and BS agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding authors
Ethics declarations
Ethics approval
This study was approved by the Ethical Committee of the University Hospitals Leuven (study reference S59182) and local committees of all participating centers. The study complied with all applicable regulatory requirements, Good Clinical Practice Guidelines, and the principles of the Declaration of Helsinki.
Consent to participate
Informed consent was obtained from all patients or their legal representative, as appropriate.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The results presented in this paper have not been published previously in whole or part, except in abstract format.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Appendix
Appendix
Appendix. “FCGG reference nephrologists” and collaborating (nephro-)pathologists of participating centers
Reference nephrologist | Center |
---|---|
An De Vriese | AZ Sint-Jan, Brugge |
Anja De Rycke | AZ Sint-Blasius, Dendermonde |
Anne-Marie Bogaert | AZ Glorieux, Ronse |
Annemie Woestenburg | AZ Voorkempen, Malle |
Bart Denys | Onze-Lieve-Vrouwziekenhuis, Aalst |
Bart Maes | AZ Delta, Roeselaere |
Domien Peeters | Sint-Trudo Ziekenhuis, Sint-Truiden |
Hilde Vanbelleghem | Jan Yperman ziekenhuis, Ypres |
Jan Donck | AZ Sint-Lucas, Ghent |
Johan Scharpé, Nele De Clippeleir | GZA, Antwerp |
Ann Colson | Kliniek Sint-Jan, Brussels |
Karen Meyvis | AZ Monica, Antwerp |
Kurt Vandepitte | Heilig-Hartziekenhuis, Lier |
Liza-Maria Reyns | AZ Sint-Lucas, Brugge |
Jacques Peeters | Ziekenhuis Oost-Limburg, Genk |
Marc Decupere | AZ Groeninge, Kortrijk |
Mark Helbert | ZNA, Antwerp |
Miranda Zeegers | AZ Turnhout, Turnhout |
Nathalie Neirynck | VITAZ, Sint-Niklaas |
Pascale Bernaert | AZ Maria Middelares, Ghent |
Tom Dejagere | Jessa Ziekenhuis, Hasselt |
Wim Lemahieu | Imeldaziekenhuis, Bonheiden |
Ben Sprangers | University Hospitals Leuven, Leuven |
Lissa Pipeleers | University Hospital Brussels, Brussels |
Rachel Hellemans | Antwerp University Hospital, Antwerp |
Steven Van Laecke | Ghent University Hospital, Ghent |
Noël Knops, Elena Levtchenko | Pediatric nephrology department, University Hospitals Leuven, Leuven |
Sevasti Karamaria, Johan Vande Walle | Pediatric nephrology department, Ghent University Hospital, Ghent |
Koen Van Hoeck, Dominique Trouet | Pediatric nephrology department, Antwerp University Hospital, Antwerp |
Reiner Mauel | Pediatric nephrology department, University Hospital Brussels, Brussels |
Pathologist | Center |
---|---|
Amélie Dendooven | Antwerp University Hospital, Antwerp and Ghent University Hospital, Ghent |
Anne Hoorens, Jo Van Dorpe, Marleen Praet | Ghent University Hospital, Ghent |
Caroline Geers | University Hospital Brussels, Brussels |
Evelyne Lerut, Priyanka Koshy, Tania Roskams | University Hospitals Leuven, Leuven |
Selda Aydin | Cliniques Universitaires Saint-Luc, Brussels |
Vasiliki Siozopoulou | Antwerp University Hospital, Antwerp |
Anne-Marie Schelfhout, Hendrik De Raeve | Onze-Lieve-Vrouwziekenhuis, Aalst |
Edwin Steenkiste, Francesca Dedeurwaerdere | AZ Delta, Roeselaere |
Ignace Dalle | AZ Sint-Lucas, Brugge |
Kristof Cokelaere, Stijn Deloose | Jan Yperman ziekenhuis, Ypres |
Pascale De Paepe | AZ Sint-Jan, Brugge |
Peter Van Eyken | Ziekenhuis Oost-Limburg, Genk |
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Deleersnijder, D., Knops, N., Trouet, D. et al. Epidemiology and clinicopathological characteristics of native kidney disease in children in Flanders, Belgium. Pediatr Nephrol 38, 1533–1545 (2023). https://doi.org/10.1007/s00467-022-05719-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-022-05719-7